Rapy. Immunity 2013, 38(1):135. 25. Fehniger TA, Caligiuri MA: Interleukin 15: biology and relevance to human disease. Blood 2001, 97(1):142. 26. Arend WP, et al: Interleukin-1 receptor antagonist: part in biology. Annu Rev Immunol 1998, 16:275. 27. Moore KW, et al: Interleukin-10. Annu Rev Immunol 1993, 11:16590. 28. Welte K, et al: Purification and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor. Proc Natl Acad Sci USA 1985, 82(5):1526530.29. Scott P: IL-12: initiation cytokine for cell-mediated immunity. Science 1993, 260(5107):49697. 30. Carpenter G, Cohen S: Epidermal development factor. J Biol Chem 1990, 265(14):7709712. 31. Yu PJ, et al: Basic fibroblast development aspect (FGF-2): the high molecular weight forms come of age. J Cell Biochem 2007, one hundred(5):1100108. 32. Warn R: Growth elements. A scattering of variables. Curr Biol 1994, four(11):1043045. 33. Byrne AM, Bouchier-Hayes DJ, Harmey JH: Angiogenic and cell survival functions of vascular endothelial growth issue (VEGF). J Cell Mol Med 2005, 9(four):77794. 34. Pitcher CJ, et al: Improvement and homeostasis of T cell memory in rhesus macaque. J Immunol 2002, 168(1):293. 35. Nagaike K, et al: Cloning of your varicella-zoster virus genome as an infectious bacterial artificial chromosome in Escherichia coli. Vaccine 2004, 22(290):4069074. 36. Tischer BK, et al: A self-excisable infectious bacterial artificial chromosome clone of varicella-zoster virus permits evaluation of the necessary tegument protein encoded by ORF9. J Virol 2007, 81(23):132003208. 37. Yoshii H, et al: Cloning of complete length genome of varicella-zoster virus vaccine strain into a bacterial artificial chromosome and reconstitution of infectious virus. Vaccine 2007, 25(27):5006012. 38. Zhang Z, et al: Genetic evaluation of varicella-zoster virus ORF0 to ORF4 by use of a novel luciferase bacterial artificial chromosome program. J Virol 2007, 81(17):9024033. 39. Cohen JI: The varicella-zoster virus genome. Curr Prime Microbiol Immunol 2010, 342:14. 40. Zhang Z, et al: Genome-wide mutagenesis reveals that ORF7 is usually a novel VZV skin-tropic factor. PLoS Pathog 2010, 6:e1000971. 41. Chaudhuri V, et al: Functions of Varicella-zoster virus ORF23 capsid protein in viral replication as well as the pathogenesis of skin infection. J Virol 2008, 82(20):102310246. 42. Selariu A, et al: ORF7 of varicella-zoster virus is a neurotropic issue. J Virol 2012, 86(16):8614624. 43. Oliver SL, et al: Mutagenesis of varicella-zoster virus glycoprotein B: putative fusion loop residues are crucial for viral replication, and also the furin cleavage motif contributes to pathogenesis in skin tissue in vivo. J Virol 2009, 83(15):7495506. 44. Brazeau E, et al: Simian varicella virus open reading frame 63/70 expression is needed for effective virus replication in culture.Inotuzumab J Neurovirol 2011, 17(3):27480.8-Hydroxy-2′-deoxyguanosine 45.PMID:24257686 Estep RD, et al: Building of an infectious rhesus rhadinovirus bacterial artificial chromosome for the analysis of Kaposi’s sarcomaassociated herpesvirus-related disease development. J Virol 2007, 81(6):2957969. 46. Robinson BA, et al: Viral interferon regulatory things reduce the induction of variety I and kind II interferon throughout rhesus macaque rhadinovirus infection. J Virol 2012, 86(four):2197211. 47. Wong CW, et al: Tracking the evolution on the SARS coronavirus using high-throughput, high-density resequencing arrays. Genome Res 2004, 14(three):39805. 48. Gray WL: Simian varicella virus: molecular virology. Curr Best Microbiol Immuno.
